ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $177,000 | -93.2% | 30,280 | -90.4% | 0.00% | -90.5% |
| Q2 2015 | $2,602,000 | -66.2% | 314,632 | -66.3% | 0.02% | -67.7% |
| Q1 2015 | $7,697,000 | +55.5% | 934,052 | +29.6% | 0.06% | +51.2% |
| Q4 2014 | $4,951,000 | +39.2% | 720,785 | +9.4% | 0.04% | +30.3% |
| Q3 2014 | $3,558,000 | -10.6% | 658,866 | +5.5% | 0.03% | -8.3% |
| Q2 2014 | $3,980,000 | +63.9% | 624,730 | +107.3% | 0.04% | +5.9% |
| Q1 2014 | $2,429,000 | +83.5% | 301,436 | +55.2% | 0.03% | +70.0% |
| Q4 2013 | $1,324,000 | +82.4% | 194,201 | +392.0% | 0.02% | +53.8% |
| Q3 2013 | $726,000 | +2.0% | 39,472 | -3.0% | 0.01% | 0.0% |
| Q2 2013 | $712,000 | – | 40,707 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |